By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioTime, Inc. 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


Key Statistics

Ownership: Public

Web Site: BioTime
Symbol: BTX

Company News
BioTime (BTX) Co-CEO Dr. Michael West To Deliver Presentation As Part Of Biotech Panel At Mauldin Economics' Strategic Investment Conference On May 24 5/24/2017 8:44:13 AM
BioTime (BTX) Reports First Quarter Results And Recent Corporate Accomplishments 5/11/2017 7:50:16 AM
BioTime (BTX) Presents Retinal Restoration Data At Association for Research in Vision & Ophthalmology 5/11/2017 6:46:49 AM
BioTime (BTX) Announces New Positive Data From OpRegen Trial In Dry-AMD 5/9/2017 6:08:36 AM
BioTime (BTX) Co-CEO Dr. Michael D. West To Present At World Advanced Therapies & Regenerative Medicine Congress On May 17 And 19 5/8/2017 8:12:27 AM
BioTime (BTX) To Announce First Quarter 2017 Results On May 10, 2017 4/26/2017 6:19:36 AM
Bay Area's BioTime (BTX) Launches New Subsidiary AgeX Therapeutics, Inc. to Develop Its Human Aging Programs 4/6/2017 8:36:57 AM
Key BioTime (BTX) Patents Upheld By European Patent Office 3/28/2017 6:44:54 AM
BioTime (BTX) Reports Fourth Quarter And Fiscal Year 2016 Financial Results And Recent Corporate Accomplishments 3/17/2017 6:27:28 AM
Data From BioTime (BTX)’s Opregen Trial In Dry-AMD To Be Presented At Association for Research in Vision & Ophthalmology On May 8 3/15/2017 7:47:52 AM